Laboratorio Reig Jofre, S.A.

BME-RJF
Madrid Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#18136
Country Rank
#102
Market Cap
284.53 M
Price
3.5
Change (%)
0.34%
Volume
20,560

Laboratorio Reig Jofre, S.A. (BME-RJF) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
09/16/2020 1.01:1 x1.01 x0.05879563 Forward
06/03/2019 1.016:1 x1.016 x0.05821349 Forward
06/16/2017 1.015:1 x1.015 x0.05729675 Forward
09/22/2015 1:20 x0.05 x0.05645 Reverse
07/12/2005 1.129:1 x1.129 x1.129 Forward

Frequently Asked Questions

  • How much would Laboratorio Reig Jofre, S.A. stock be worth if it never split?
    If Laboratorio Reig Jofre, S.A. (stock symbol: BME-RJF) had never undergone any stock splits, its price per share today would be approximately 0.21 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1.01-for-1) that occurred on 09/16/2020.
  • Laboratorio Reig Jofre, S.A. (stock symbol: BME-RJF) has undergone a total of five stock splits. The most recent split occurred on 09/16/2020. One share bought prior to the first split on 07/12/2005 would now equal 0.06 shares.
  • Laboratorio Reig Jofre, S.A. (stock symbol: BME-RJF) has undergone five stock splits in its history. The most recent split, a 1.129-for-1 split, occurred on 09/16/2020. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.